Importance of calibration method in central blood pressure for cardiac structural abnormalities

American Journal of Hypertension

Volumn 29, Issue 9, 2016, Pages 1070-1076

  Negishi, Kazuaki ^a   Yang, Hong ^a   Wang, Ying ^a   Nolan, Mark T ^a   Negishi, Tomoko ^a   Pathan, Faraz ^a   Marwick, Thomas H ^a   Sharman, James E ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Blood pressure determinations; Blood vessels; Cardiovascular diagnostic technique; Heart function tests; Hypertension; Pulse wave analysis

Indexed keywords

AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE; BRACHIAL OSCILLOMETRY; CALIBRATION; CARDIAC STRUCTURAL ABNORMALITY; CARDIOVASCULAR RISK; CENTRAL BLOOD PRESSURE; CENTRAL SYSTOLIC BLOOD PRESSURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; DISCRIMINANT ANALYSIS; FEMALE; HEART DILATATION; HEART DISEASE; HEART LEFT ATRIAL DILATATION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; OSCILLOMETRY; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; SYSTOLIC BLOOD PRESSURE; VERY ELDERLY; BLOOD PRESSURE MEASUREMENT; COMPARATIVE STUDY; HEART ATRIUM; HEART FAILURE; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; ANTIHYPERTENSIVE THERAPY; BRACHIAL ARTERY; DISEASE ASSOCIATION; HEART ATRIUM ENLARGEMENT; HEART LEFT ATRIUM; HEART LEFT VENTRICLE FAILURE; HYPERTENSION; NON INVASIVE BLOOD PRESSURE MONITOR; OSCILLOMETER; PREDICTIVE VALUE; PROSPECTIVE STUDY; RISK FACTOR;

AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CALIBRATION; FEMALE; HEART ATRIA; HEART FAILURE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE;

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

EID: 84991380028     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpw039     Document Type: Article

References (31)

1. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, Hughes AD, Thurston H, O'Rourke M; CAFE Investigators; Anglo- Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure- lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113:1213-1225.
2. Cheng HM, Chuang SY, Sung SH, Yu WC, Pearson A, Lakatta EG, Pan WH, Chen CH. Derivation and validation of diagnostic thresholds for central blood pressure measurements based on long-term cardiovascular risks. J Am Coll Cardiol 2013; 62:1780-1787.
3. Huang CM, Wang KL, Cheng HM, Chuang SY, Sung SH, Yu WC, Ting CT, Lakatta EG, Yin FC, Chou P, Chen CH. Central versus ambulatory blood pressure in the prediction of all-cause and cardiovascular mortalities. J Hypertens 2011; 29:454-459.
4. Millasseau S, Agnoletti D. Non-invasive estimation of aortic blood pressures: a close look at current devices and methods. Curr Pharm Des 2015; 21:709-718.
5. Weber T, Wassertheurer S, Rammer M, Maurer E, Hametner B, Mayer CC, Kropf J, Eber B. Validation of a brachial cuff-based method for estimating central systolic blood pressure. Hypertension 2011; 58:825-832.
6. Pucci G, Cheriyan J, Hubsch A, Hickson SS, Gajendragadkar PR, Watson T, O'Sullivan M, Woodcock-Smith J, Schillaci G, Wilkinson IB, McEniery CM. Evaluation of the Vicorder, a novel cuff-based device for the noninvasive estimation of central blood pressure. J Hypertens 2013; 31:77-85.
7. Manios E, Vemmos K, Tsivgoulis G, Barlas G, Koroboki E, Eleni K, Spengos K, Zakopoulos N. Comparison of noninvasive oscillometric and intra-arterial blood pressure measurements in hyperacute stroke. Blood Press Monit 2007; 12:149-156.
8. Umana E, Ahmed W, Fraley MA, Alpert MA. Comparison of oscillometric and intraarterial systolic and diastolic blood pressures in lean, overweight, and obese patients. Angiology 2006; 57:41-45.
9. Kobayashi H, Kinou M, Takazawa K. Correlation between the brachial blood pressure values obtained using the cuff method and the central blood pressure values obtained invasively. Intern Med 2013; 52:1675-1680.
10. Cloud GC, Rajkumar C, Kooner J, Cooke J, Bulpitt CJ. Estimation of central aortic pressure by SphygmoCor requires intra-arterial peripheral pressures. Clin Sci (Lond) 2003; 105:219-225.
11. Smulyan H, Sheehe PR, Safar ME. A preliminary evaluation of the mean arterial pressure as measured by cuff oscillometry. Am J Hypertens 2008; 21:166-171.
12. Protogerou AD, Argyris AA, Papaioannou TG, Kollias GE, Konstantonis GD, Nasothimiou E, Achimastos A, Blacher J, Safar ME, Sfikakis PP. Left-ventricular hypertrophy is associated better with 24-h aortic pressure than 24-h brachial pressure in hypertensive patients: the SAFAR study. J Hypertens 2014; 32:1805-1814.
13. Wassertheurer S, Baumann M. Assessment of systolic aortic pressure and its association to all cause mortality critically depends on waveform calibration. J Hypertens 2015; 33:1884-1888.
14. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA Guidelines for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 62:e147-e239.
15. Franssen PM, Imholz BP. Evaluation of the Mobil-O-Graph new generation ABPM device using the ESH criteria. Blood Press Monit 2010; 15:229-231.
16. Wei W, Tölle M, Zidek W, van der Giet M. Validation of the Mobil- O-Graph: 24 h-blood pressure measurement device. Blood Press Monit 2010; 15:225-228.
17. Mahieu D, Kips J, Rietzschel ER, De Buyzere ML, Verbeke F, Gillebert TC, De Backer GG, De Bacquer D, Verdonck P, Van Bortel LM, Segers P; Asklepios investigators. Noninvasive assessment of central and peripheral arterial pressure (waveforms): implications of calibration methods. J Hypertens 2010; 28:300-305.
18. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F; Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31:1281-1357.
19. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015; 28:1-39.e14.
20. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44:837-845.
21. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27:157-172.
22. Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011; 30:11-21.
23. Sharman JE. Central pressure should be used in clinical practice. Artery Research 2015; 9:1-7.
24. Cheng HM, Sung SH, Chuang SY, Pearson A, Tufanaru C, White S, Yu WC, Chen CH. Diagnostic performance of a stand-alone central blood pressure monitor: application of central blood pressure in the diagnosis of high blood pressure. Am J Hypertens 2014; 27:382-391.
25. Sharman JE, Marwick TH, Gilroy D, Otahal P, Abhayaratna WP, Stowasser M; Value of Central Blood Pressure for GUIDing ManagEment of Hypertension Study Investigators. Randomized trial of guiding hypertension management using central aortic blood pressure compared with best-practice care: principal findings of the BP GUIDE study. Hypertension 2013; 62:1138-1145.
26. Matsui Y, Eguchi K, O'Rourke MF, Ishikawa J, Miyashita H, Shimada K, Kario K. Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients. Hypertension 2009; 54:716-723.
27. Manisty CH, Zambanini A, Parker KH, Davies JE, Francis DP, Mayet J, McG Thom SA, Hughes AD; Anglo-Scandinavian Cardiac Outcome Trial Investigators. Differences in the magnitude of wave reflection account for differential effects of amlodipine- versus atenolol-based regimens on central blood pressure: an Anglo-Scandinavian Cardiac Outcome Trial substudy. Hypertension 2009; 54:724-730.
28. Agnoletti D, Zhang Y, Salvi P, Borghi C, Topouchian J, Safar ME, Blacher J. Pulse pressure amplification, pressure waveform calibration and clinical applications. Atherosclerosis 2012; 224:108-112.
29. Mitchell GF. Central pressure should not be used in clinical practice. Artery Res 2015; 9:8-13.
30. Vlachopoulos C, Aznaouridis K, O'Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 2010; 31:1865-1871.
31. Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, Go AS, Harrell FE Jr, Hong Y, Howard BV, Howard VJ, Hsue PY, Kramer CM, McConnell JP, Normand SL, O'Donnell CJ, Smith SC Jr, Wilson PW; American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases and Emerging Risk Factors and the Stroke Council. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009; 119:2408-2416.